(Q28139694)
Statements
Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study (English)
0 references
June 2000
0 references
101
0 references
6
0 references
372-80
0 references